Hdfc Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 19-10-2026
NAV ₹20.22(R) -1.3% ₹20.96(D) -1.29%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 16.24% 26.33% -% -% -%
Direct 17.55% 27.83% -% -% -%
Benchmark
SIP (XIRR) Regular 16.93% 18.93% -% -% -%
Direct 18.25% 20.35% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 1976 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 19-10-2026

Scheme Name NAV Rupee Change Percent Change
HDFC Pharma and Healthcare Fund - IDCW Option 20.22
-0.2700
-1.3000%
HDFC Pharma and Healthcare Fund - Growth Option 20.22
-0.2700
-1.3000%
HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan 20.96
-0.2700
-1.2900%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 20.96
-0.2700
-1.2900%

Review Date: 19-10-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -8.53 -5.20
-7.97
-8.83 | -6.35 13 | 17 Average
3M Return % -3.77 -1.40
-4.40
-7.14 | -1.39 7 | 17 Good
6M Return % 13.50 14.47
10.92
5.22 | 17.28 6 | 17 Good
1Y Return % 16.24 14.83
7.87
-0.52 | 16.24 1 | 16 Very Good
3Y Return % 26.33 19.60
18.52
14.89 | 26.33 1 | 11 Very Good
1Y SIP Return % 16.93
7.11
-19.70 | 20.51 2 | 16 Very Good
3Y SIP Return % 18.93
9.46
-1.46 | 18.93 1 | 11 Very Good
Return data last Updated On : Oct. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -8.46 -5.20 -7.88 -8.73 | -6.29 13 | 17 Average
3M Return % -3.51 -1.40 -4.09 -6.82 | -0.99 8 | 17 Good
6M Return % 14.11 14.47 11.66 5.95 | 18.20 6 | 17 Good
1Y Return % 17.55 14.83 9.33 0.89 | 17.55 1 | 16 Very Good
3Y Return % 27.83 19.60 19.97 15.92 | 27.83 1 | 11 Very Good
1Y SIP Return % 18.25 8.60 -18.57 | 22.44 2 | 15 Very Good
3Y SIP Return % 20.35 10.80 -0.05 | 20.35 1 | 10 Very Good
Return data last Updated On : Oct. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Hdfc Pharma And Healthcare Fund NAV Regular Growth Hdfc Pharma And Healthcare Fund NAV Direct Growth
19-10-2026 20.215 20.956
16-10-2026 20.481 21.23
15-10-2026 20.476 21.224
14-10-2026 20.526 21.275
13-10-2026 20.742 21.498
12-10-2026 20.775 21.532
09-10-2026 20.805 21.561
08-10-2026 20.646 21.396
07-10-2026 21.149 21.916
06-10-2026 21.219 21.988
05-10-2026 21.016 21.777
01-10-2026 21.213 21.979
30-09-2026 21.181 21.944
29-09-2026 21.613 22.392
28-09-2026 21.54 22.315
25-09-2026 21.826 22.61
24-09-2026 21.916 22.702
23-09-2026 22.081 22.873
22-09-2026 21.904 22.689
21-09-2026 22.101 22.892

Fund Launch Date: 04/Oct/2023
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies
Fund Benchmark: BSE Healthcare Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.